Jim Cramer is Optimistic About Novartis’ (NVS) Cancer Drug

We recently published 14 Stocks on Jim Cramer’s Radar.  Novartis AG (NYSE:NVS) is one of the stocks on Jim Cramer's radar. Pharmaceutical firm Novartis AG (NYSE:NVS)’s shares are up by 44% over the past year and by 7.6% year-to-date. The tail end of 2025 saw several analysts discuss the firm. For instance, Morgan Stanley upgraded the shares to Overweight and increased the share price target to CHF110 from CHF108. The bank pointed out that Novartis AG (NYSE:NVS)’s shares had suffered excessively after the ...